These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11511144)

  • 21. [Results of treatment of lupus nephritis in children. Own experience].
    Kwinta-Rybicka J; Sancewicz-Pach K
    Pol Merkur Lekarski; 2000 Apr; 8(46):232-4. PubMed ID: 10897625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis.
    Vachvanichsanong P; Dissaneewate P; McNeil E
    Int Urol Nephrol; 2013 Oct; 45(5):1301-8. PubMed ID: 23225077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overwhelming septic cavernous sinus thrombosis in a woman after combination of high-dose steroid and intravenous cyclophosphamide therapy for lupus nephritis.
    Chen YC; Cheng TT; Lai HM; Wu CH
    Lupus; 2000; 9(1):78-9. PubMed ID: 10713653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential therapies for proliferative lupus nephritis.
    Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
    N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?
    Li EK; Tam LS; Zhu TY; Li M; Kwok CL; Li TK; Leung YY; Wong KC; Szeto CC
    Rheumatology (Oxford); 2009 Aug; 48(8):892-8. PubMed ID: 19478041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential therapies for proliferative lupus nephritis.
    Gelber AC; Christopher-Stine L; Fine DM
    N Engl J Med; 2004 Jun; 350(24):2518-20; author reply 2518-20. PubMed ID: 15195341
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
    Lau KK; Ault BH; Jones DP; Butani L
    J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
    Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
    [No Abstract]   [Full Text] [Related]  

  • 29. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
    Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction and maintenance therapy in proliferative lupus nephritis.
    Ponticelli C; Glassock RJ; Moroni G
    J Nephrol; 2010; 23(1):9-16. PubMed ID: 20091481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.
    Boletis JN; Ioannidis JP; Boki KA; Moutsopoulos HM
    Lancet; 1999 Aug; 354(9178):569-70. PubMed ID: 10470708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction therapy for active lupus nephritis: mycophenolate mofetil is superior to cyclophosphamide.
    Elliott JR; Manzi S
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):354-5. PubMed ID: 16932717
    [No Abstract]   [Full Text] [Related]  

  • 36. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
    Glicklich D; Acharya A
    Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T; Nozawa T; Kikuchi M; Nagahama K; Okudela K; Miyamae T; Imagawa T; Nakamura T; Mori M; Yokota S; Tsutsumi H
    Mod Rheumatol; 2015 Mar; 25(2):210-4. PubMed ID: 25159157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J; Hu W; Xie H; Zhang H; Chen H; Zeng C; Liu Z; Li L
    Lupus; 2007; 16(9):707-12. PubMed ID: 17728363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
    Jedlickova H; Bohmová J; Sirotkova A
    Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
    [No Abstract]   [Full Text] [Related]  

  • 40. The long-term prognosis of lupus nephritis patients treated with intravenous cyclophosphamide.
    Matsuyama N; Morimoto S; Tokano Y; Amano H; Nozawa K; Isonuma H; Hashimoto H; Takasaki Y
    Intern Med; 2010; 49(9):823-8. PubMed ID: 20453401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.